Preliminary data from a phase 1b extension study (NCT05292911) involving 64 individuals with MRI-PDFF 10% and BMI 28 kg/m 2 demonstrated that 50%, 44%, and 60% of participants presenting baseline alanine aminotransferase (ALT) 30 IU/L reached combined MRI-PDFF reduction 30% and ALT reduction 17 IU/L at pemvidutide doses of 1.2, 1.8, and 2.4 mg, respectively, vs
Angew Chem Int Ed Engl (2015) 54(37):108337
Control of brown and beige fat development
Rest assured, our team of specialists is here to guide you through every stage of your wellness journey, providing support and advice whenever needed
Semaglutide, a medication used for weight management and type 2 diabetes, is associated with various side effects